tm
Seeing Is Believing
tm
Seeing Is Believing
NMRA is currently covered by 7 analysts with an average price target of $6.5. This is a potential upside of $6.13 (1656.76%) from yesterday's end of day stock price of $0.37.
Neumora Therapeutics's activity chart (see below) currently has 45 price targets and 54 ratings on display. The stock rating distribution of NMRA is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 8.89% with an average time for these price targets to be met of 17.73 days.
Highest price target for NMRA is $14, Lowest price target is $3, average price target is $6.5.
Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 13-Jul-2026. First documented stock forecast 10-Oct-2023.
Currently out of the existing stock ratings of NMRA, 4 are a HOLD (33.33%), 8 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Jul-2026
$5
$3.96 (380.77%)
$7
3 months 19 days ago
(13-Jul-2026)
0/11 (0%)
$3.4 (212.50%)
Buy Since 08-Jul-2024
$4
$2.36 (143.90%)
$5
4 months 14 days ago
(18-Jun-2026)
0/6 (0%)
$2.49 (164.90%)
Buy Since 01-Oct-2024
$7
$5.36 (326.83%)
$18
4 months 16 days ago
(16-Jun-2026)
0/8 (0%)
$5.44 (348.72%)
Buy Since 22-Jul-2024
$5
$3.36 (204.88%)
$8
4 months 16 days ago
(16-Jun-2026)
0/8 (0%)
$3.44 (220.51%)
Buy Since 31-Mar-2026
$14
$12.36 (753.66%)
7 months 1 days ago
(31-Mar-2026)
0/2 (0%)
$12.05 (617.95%)
What is NMRA (Neumora Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on NMRA (Neumora Therapeutics)?
Which analyst has the most public recommendations on NMRA (Neumora Therapeutics)?
Which analyst is the currently most bullish on NMRA (Neumora Therapeutics)?
Which analyst is the currently most reserved on NMRA (Neumora Therapeutics)?
